Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Kimberly Gentile currently holds 175,000 shares of Biohaven Pharmaceutical Holding Co Ltd. (BHVN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kimberly Gentile has been a net seller of BHVN stock. They have purchased $0 and sold $6.1M worth of shares.
Kimberly Gentile's most recent insider trade was on Feb 27, 2026, when they sold 175,000 shares at $0.00 per share.
Kimberly Gentile serves as Executive at Biohaven Pharmaceutical Holding Co Ltd. (BHVN). They have executed 67 insider transactions totaling $6.1M over their tenure at the company.
Kimberly Gentile holds the position of Executive at Biohaven Pharmaceutical Holding Co Ltd., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Kimberly Gentile has shown a selling trading pattern, with $0 in total purchases and $6.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Kimberly Gentile was on Oct 3, 2022, when they sold $1.7M worth of BHVN shares. This transaction involved 11,653 shares at $148.50 per share.
Kimberly Gentile currently owns 175,000 shares of Biohaven Pharmaceutical Holding Co Ltd. (BHVN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Kimberly Gentile's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Kimberly Gentile has 67 Form 4 filings on record as an insider at Biohaven Pharmaceutical Holding Co Ltd..
Set alerts for Kimberly Gentile and 40,000+ other insiders.